RxDoctor Payments Data
★ My doctorsLook up a doctor →

Jessica Pogran

Child & Adolescent Psychiatry · Long Branch, NJNPI 1760794010

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 158 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Supernus Pharmaceuticals, Inc. at 24.9% of the total. 2025 is the largest year on record at $664, more than ten times the $39 reported in 2020.

$2,282in general payments, 2019–2025

Across 158 payments — averaging $14.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supernus Pharmaceuticals, Inc.$569
  • Otsuka America Pharmaceutical, Inc.$480
  • Corium, LLC$290
  • Ironshore Pharmaceuticals Inc.$257
  • Collegium Pharmaceutical, Inc.$127
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$121
  • plus $438 from 11 others

What the payments were for

  • Food & beverage$2,282100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Supernus Pharmaceuticals, Inc.47$569
Otsuka America Pharmaceutical, Inc.29$480
Corium, LLC17$290
Ironshore Pharmaceuticals Inc.18$257
Collegium Pharmaceutical, Inc.8$127
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)8$121
Tris Pharma Inc7$96
Neos Therapeutics, LP5$71
AbbVie4$63
Johnson & Johnson4$62
Lundbeck LLC3$38
Sunovion Pharmaceuticals Inc.3$34
E.r. Squibb & Sons, L.L.C.1$16
Axsome Therapeutics, Inc.1$16
Vanda Pharmaceuticals Inc.1$16
Teva Pharmaceuticals USA, Inc.1$14
Takeda Pharmaceuticals U.S.A., Inc.1$13

How this compares

$2,282 in reported general payments places this provider in the 85th percentile of 137 child & adolescent psychiatry providers in New Jersey.

See all child & adolescent psychiatry providers in New Jersey →

Other child & adolescent psychiatry in Long Branch

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →